Conference Call Participants
Richard Vosser – JPMorgan Chase & Co, Research Division
Presentation
Richard Vosser
JPMorgan Chase & Co, Research Division
Welcome to the JPMorgan Healthcare Conference. I’m Richard Vosser, European pharma analyst for JPmorgan. It’s my great pleasure to introduce Sanofi. From the conference we have 3 of the very senior management here to entertain us now. Paul Hudson, CEO; François-Xavier Roger, CFO; and Houman Ashrafian.
Paul Hudson
CEO & Director
You fully butchered every name.
Richard Vosser
JPMorgan Chase & Co, Research Division
Every name, every year.
Paul Hudson
CEO & Director
Every year.
Richard Vosser
JPMorgan Chase & Co, Research Division
It’s consistent, but that’s what we like. So I better shut up then and hand to Paul for a few introductory remarks, and then we’re going to chat together.
Paul Hudson
CEO & Director
Thank you, Mr. Vosser. We appreciate that.
Richard Vosser
JPMorgan Chase & Co, Research Division
That was wrong, Paul.
Paul Hudson
CEO & Director
Great — we only have a handful of slides, but I’ll just — we’ll put a — I have 1, Houman has a couple. Thank you for making the time. It’s been an extremely busy year last year for us, and we had a couple of challenges in R&D, which I think are well communicated. We also made a very important commercial progress. We were growing 8.7% through Q3. Script trends, if they stay consistent through the remainder of the year across the major drivers of that, we’re going to be close to double-digit growth. That double-digit growth profile we think we can maintain for the next half decade plus. And that puts us in quite a rare group
